Noa Simchoni

Noa Simchoni, MD, PhD, is a Clinical Instructor at the University of California, San Francisco (UCSF) School of Medicine. Her research focuses on immunology, particularly primary immunodeficiency syndromes and autoimmune disorders, with a strong emphasis on COPA syndrome, Toll-like receptor (TLR) signaling, and genetic variations impacting immune cell development.

• Key Research Areas: Immunology, Autoimmune Disorders, Genetic Variation in Immune Diseases, Lung Diseases (Interstitial), Molecular Biology.

Dr. Simchoni's work spans functional validation of genetic variants, immune cell dynamics (e.g., T and B cell repertoires), and microbiota-immune system interactions. Her recent publications highlight COPA syndrome pathogenesis, STING pathway activation, and clinical guidelines for immune deficiency management.

Scientific trends in her publications include:

• Autoimmune mechanisms in COPA syndrome
• TLR signaling in B and T cell responses
• Microbiota regulation of mucosal immunity

She has collaborated with researchers like Anthony Shum, Brett Elicker, and Amy Berger, though no awards or grants are explicitly listed in the data. Her work also addresses clinical practice implementation for diseases like COVID-19 and rare lung pathologies.